Vol. 146, No. 2, 1987
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS Pages 889-897
July 31,1987
THE EFFECT OF EPIDERMAL GROWTH FACTOR ON CHRONOTROPIC RESPONSE IN CARDIAC CELLS IN CULTURE Simon
W. Rabkin 1
University
"*,
Paul
Cardiovascular of British
Research Columbia,
20ncogen Received
June
23,
Sunga,
Inc.,
and
Sigrid
Laboratories, Vancouver,
Seattle
Myrdal
B.C.,
3
CANADA
WA
1987
SUMMARY: Cardiac chronotropic response to epidermal growth factor (EGF) was assessed in chick embryonic ventricular cell aggregates. EGF at a concentration of 10 ug/mL but not at 5 ug/mL produced a significant (~~0.05) increase in cardiac beating rate. This was evident within 10 min, reached a peak at about 15 min and remained at that level for 1.5 hr or the rest of the observation period. The effect of EGF on cardiac automaticity was reduced but not abolished at a lower temperature (22oC) that is known to decrease the affinity of the EGF receptor and reduce the internalization of EGF. Hypothermia did not change the maximum increase in heart rate response fromisoproterenol although it altered the pattern of the response. Beta adrenoreceptor blockade with metoprolol only slightly altered the response to EGF. These data indicate that EGF produces functional effects'on the heart that may be mediated through EGF receptor linked mechanisms. o 1987 Academic press, inc.
The recognition
of
receptor
for
cellular
responses
however,
have
received
beating
rate
cardiac (1)
this
and that
2Present CANADA
little
ion
concentrations the
address: V6H 3Nl.
Faculty
that
dependent
and reduced
of
EGF with
and of
the
requests
Medicine,
growth
has improved
factor
our
EGF alters for the
the
ion
we chose
cell
for 4500
is
fluxes
cell
highly
reprints Oak Street,
of
EGF, alter
across
membranes
their
rhythmicity
membrane the
(2,3).
effects
temperature temperature
should
of
EGF would
of
to examine
environmental
and the
effects
that
generation
myocardial
(EGF)
understanding
The cardiac
systems.
We hypothesized
mechanisms
blockade
correspondence
cell
across
possible
The association
epidermal
attention.
are
adrenoreceptor
whom all
of
cells
study
lTo
in a variety
of
surface
cardiac
To further
EGF.
on cell
on data
in
to
peptide
existence
based
on changes
beta
the
of
on the
response
dependent.
be addressed. Vancouver,
B.C ,
0006-291X/87 889
$1.50
Copyright 0 I987 by Academic Press, Inc. All rights of reproduction in any form reserved.
Vol. 146, No. 2, 1987 Reduction
of
and also
study
this
to which
of
whether
temperature
decreases
temperature
BIOCHEMICALAND
EGF-receptor EGF affected
was influenced
it
decreases subsequent the
cell
EGF binding
to
its
internalization is
interaction.
BIOPHYSICALRESEARCH
exposed
(1,4).
provides
The purpose
cardiac
chronotropic
by beta
adrenoreceptor
cell
of
(rate)
this
response
blockade
or
surface Thus,
a useful
COMMUNICATIONS receptor
reduction
approach study
in
to the
was to
determine
and to determine different
whether
environmental
temperatures.
MATERIALS Cell
AND METHODS
Culture
Chick embryonic ventricular cells were cultured using the method of DeHaan as we have previously described (5). Briefly, white Leghorn eggs were incubated in an automatic incubator (March Rollex, California, USA) for 7 days at 37.8 degrees C and 87% humidity. Hearts were then isolated under sterile conditions from the 7 day chick embryo. Bllod and connective tissue were removed under a dissecting microscope in a solution of balanced salts (DMS8) with the following NaCl 116 mM, KC1 5.4 mM, NaH2P04*H20 0.8 mM, Na2HP04*7H20 1 mM composition: and dextrose 5.6. mM. Disaggregation was carried out by 5 minute digestions in 0.005% trypsin (Gibco Laboratories, Burlington, Ontario), 0.1% BSA and 1*10 7 Dornase units DNase per mL DMS8 (Worthington Biochemicals, Frederic, NJ, USA) at 37 degrees C. After three digestions, the digests were diluted 1:5 in culture medium and the cells centrifuged for three minutes at 1000 G in a clinical centrifuge (International Equipment Co., Needham Heights, Mass., USA). Cell aggregates were prepared as follows: Cells were collected and the number of cells/ml counted using a hemocytometer. Cells were diluted in medium in 25 mL Erlenmeyer flasks so that total volume was 3mL with approximately 3.0 x 10 6 cells/flask (Falcon, Becton Dickinson, Oxnard, CA, USA). Cells were maintained in medium 919A (20% M199, 73% DBSK buffer, 6% fetal bovine serum, penicillin at 100 units per mL, streptomycin at 10 ug/mL, plus fungizone 0.25 ug/mL). DBSK buffer had the following composition: NaCl 116 mM, NaH2P04*H2 1.0 mM, MgS04.7 H20 0.8mM,NaHP04*H2 1 mM, dextrose 5.6 mM, CaC12 1.8 mM, and NaHC03 26 mM. The flasks were placed on the platform of a variable speed Rotator (American Rotator, Can Lab) in the incubator at 60 RPM. After 40 to 72 hours, as needed, flasks were emptied into a 35 mm x 10 mm petri dish and swirled briefly to centre the aggregates which are allowed to stick to the bottom for about 30 min in the incubator. Beating rates were determined as outlined previously (5). A pair of petri dishes are placed in larger dishes with intake for 5% CO2 in air, bubbled through water on the stage of a Wilovertinverted micrgscope in a connected infants incubator. Constant temperature was maintained at 37 C by a heat lamp and tbermostat control with the temperature probe on the microscope stage. After 30 min equilibrium, a group of 5 or 6 aggregates/dish were selected and the contraction rate recorded. When the beating rate was consistent, a sham procedure was conducted. Two mL of medium was withdraen, placed in a petri dish within the incubator, mixed well and returned to the aggregate dish. When the beating rate was stable (constant), the drug was added to the withdrawn medium and returned to the aggregate dish in a similar manner to the sham procedure. Beating rates were recorded for each aggregate every 2 min for first 30 min, every 3 min for next 30 min, and every 5 min for the second hour. Drugs
and Chemicals
Epidermal (Lexington,
growth factor was obtained from Collaborative Missouri, USA). Isoproterenol was obtained 890
Research from Sigma
Inc. Chem ica ,l
Vol. 146,No.
co., St. Louis, Pharmaceuticals. Canada). Data
BlOCHEMlCALANDBlOPHYSlCALRESEARCHCOMMUNlCATlONS
2, 1987 Missouri, Culture
USA. media
Metoprolol tartrate was obtained from
was a gift from Gibco (Burlington,
Astra Ontario,
Analysis
Beating
rates
per minute and percent change from baseline were calculated as the mean and one standard deviation. Hypothesis testing analysis of variance. The null hypothesis was rejected if the probability of a Type I error was less than 5% (i.e., ~~0.05).
and presented
used
RESULTS Cardiac
cell
experiment, hours dish of
aggregates
beating
(Figure did
rates
1).
not
affect
at
that
at
the
control.
after
the
its
attained
were
found
to
of
EGF at
beating in
an increase
for
that an hour
EGF concentration
Analysis
of
the
a constant
rate.
be stable
rate.
addition,
level
higher
at
The addition
10 mcgm/mL resulted
10 minutes
beat
the
for
The addition in
rate
its
peak
and a half.
change
in
the
conditions
periods
of
beating
reaches
the
concentration
in excess of
EGF at which
at
was evident
15 minutes
(p
greater
rate
beating
rate
than
compared
the to the
37Oc. 0
Control
0
EGF lOpg/ml
A
EGF 5pg/ml
0 20 SHAM
Figure
+
Drug
60
40
80
100
120
Time (minutes)
1. This shows the beating rate of myocardial cell aggregates in control cells that had not received EGF (O), in other cells that received EGF 5 ug/ml (A), and 10 ug/ml (0). The data is The aggregates were observed displayed as the mean -+ 1 S.D. for 120 min.
891
2
and remains
loo-
4
of
within
120
m-
the
a concentration
in
beating
of
5 mcgm/mL in the
The increase
was significantly
percent
Under
Vol. 146, No. 2, 1987
BlOCHEMlCALANDBlOPHYSlCALRESEARCHCOMMUNlCATlONS
20 E ‘s t%
10
E s
0
$ El -10
6 ZR
-20
0
EGF 10pglml
A
EGF 5@g/ml
-30 20
I
/
I
I
I
40
60
60
100
120
Time (minutes) This 2. aggregates exposed
Figure
shows the percent change in beating rate of in controls, those exposed to EGF 5 ug/ml to EGF 10 ug/ml. The data is from Figure 1.
baseline
data
illustrates
of
with
rate
(Figure
2).
cells
period the
higher
minutes
that
However,
in
to
the
two-hour
when cells
were
was evident. of
almost the
the
prevented
of
period.
in heart
a 15% increase
in
over
rate
the After
decreased
EGF, 10 ug/mL, reduction rate
in with
beating about
but
22W
being
was not
decreased
a reduction
in
after
EGF antagonized
rate
produced
by 22oC. the
evident
rate
EGF, 10 ug/mL,
However,
Heart
EGF.
during
22OC.
892
to
slowing
at
temperatures,
3).
(~(0.05)
exposed
37OC.
lower
(Figure
a significant
22OC than
heart
15
temperature.
persistently rate
but
and a half.
of
not
rate
40 min,
rate
within
hour
with
continued
The beating. at
next
aggregates
gradually
period.
rate
by environmental
with
a two-hour
beating
temperature
cell
dependent
less
the
cell
populations
over
alter
lower
isolated
to 22oC.
(~~0.05)
the
the
baseline
was associated
Initially,
observation
to
the
in control
not
was affected
was time
Beating
exposed
reduction
rate
at
rate
EGF did
thereafter
temperature
rate
heart from
of
EGF produces
minimally
exposed
was significantly in cells
of
automaticity
in
of
deviation
EGF was reduced
beating
The decrease
rest
little
in environmental
decrease
stability
Low concentrations
increases
cardiac
Reduction
the
showing
concentration
The response
over
the
myocardial and those
rate
did
difference
not
increase and
To adjust between
for
Vol. 146, No. 2, 1987
BIOCHEMICALAND
BIOPHYSICALRESEARCH
COMMUNICATIONS
20
=t 3 m"
10
E ;
0 El s -10
6
-20
0
Control
0
EGF~OM$TI
-30
T
2;
4'0
6b
8b
160
120
Time (minutes) Figure
control
cells
(Figure
4).
22oc.
and cells The effect
However,
Beating addition
3. This maintained and cells
the percent 22 C. Control had received
exposed of
increased
to
EGF was calculated
of
heart
an effect
significantly
isoproterenol
change in cardiac cells that had EGF at 10 ug/ml
EGF to increase
EGF had less
rate of
shows at that
at (~~0.05)
1°-'Mto
the
media
at
rate
the
beating rate in not received EGF (0) are compared.
both
temperatures
was evident
lower
temperature.
in this
preparation
(Figure
5).
At
cells (0)
37OC,
at
37oC and
after the
maximum
30
a 3Pc. A 22'C. -30
I
20
Figure
4. This compares control cells at Figure 2).
40
Tirnr(minutesI
the difference 22 C (data from
893
/ 80
in beating Figure 4)
100
rate between and 37 C (data
the
120
EGF and from
Vol. 146, No. 2, 1987
BIOCHEMICAL
AND BIOPHYSICALRESEARCH
COMMUNICATIONS
40
30 is) = $
20
0”
E .E
10
s i%J 0 5 *
-10
0
20
40
60
SO
100
120
Time (minutes) Figure
increase the
5. This exposed
in heart
to
shows the percent isoproterenol
rate
was about
120 min observation.
line
within
the
decreased
so that
to produce
it
was back
of
isoproterenol.
response
to
EGF and isoproterenol
This
of
was a greater
To determine beta
adrenoreceptors,
used.
Metoprolol
of
about
produced mainly rate
reduction
slowing of
metoprolol
in EGF.
of
the in
initial
heart
rate
after
There
were
no
20 to
3 versus under
rate
rate
EGF.
beating
metoprolol significant
120 min
after 894
of
EGF at
a
22OC.
through
metoprolol
was
to a maximum Metoprolol
to
EGF that increase
not between
to these
was evident in
presence
was clearly
exposure
in the
conditions.
rate
5% in the
differences
gradually
5) shows
to
period.
base-
hypothermia
was mediated
The maximum
to about
but
even
Figure
agent
response
35% above
(20 min)
response
blocking
throughout
of
hypothermic
the
decreased
heart
15% was reduced
from
pattern
120 min observation the
cells
isoproterenol
was evident
initial
than
in
about
The effect
EGF on beating
20 min after
EGF of about
presence
EGF with
the
effect
to
of
rate
two agents
(~~0.05)
end of
the
adrenoreceptor
significantly
a slight
after
beta
addition
22OC (Figure
sustained effect
the
the
The marked the
the
of
at
increased
beating
rate
and was sustained
by 20 min.
in
in these
and more
45% near
during
baseline
Comparison
response
whether
to
rate the
reduction
presence
kind
after
ca&diac beahing 37 C and 22 C.
baseline
beating
few minutes
a time-dependent
different
35% above
At 22OC,
first
than e in lo- 9 M at
at
beating of
metoprol
evident
in
EGF alone
agents(Figure
01.
and 6).
Vol. 146, No. 2, 1987
BIOCHEMICAL
AND BIOPHYSICALRESEARCH
COMMUNICATIONS
0 EGF lO&mL A
lo-%
Metoprolol
0 Metoprolol
2b
--
0
4b
I
10.’ + EGF lOW/mL
e'o
IdO
40
Tim~(minutes) Figure
6. This shows the aggregates exposed of EGF 10 ug/mL.
percent change to metoprolol
in cardiac beating 10m8M in the presence
rate
in
or
cell
absence
DISCUSSION The major
contribution
produce
definite
unclear
but
chick
heart
is
debated.
et
al
effects
its
potential
has
been
of
the
effects
of
on cardiac
The present EGF was not marked
to
study mediated
The generation well
as the
function.
growth
EGF was shown
role
The presence
of
found
EGF in mouse
heart
However,
in as well
transport,
(9)
cardiac
is
cells
cardiac
cells
while of
supports
from tissue Kasselberg
EGF on ion a role
chronotropic
as adrenergic
to
heart
EGF in
th;- effect
neurons
and specifically
in the
of mesenchymal
(6).
and cholinergic
ion
that Its
the
human heart.
also
found
through
that beta
in these
for
responses
because
and cholinergic
cells
the
increase
in
beating
adrenoreceptors. had a very
minor
rate
produced
Beta
blockade
that
effect
on the
heart
by produced rate
EGF.
The mechanism attractive
(7)
is
automaticity.
bradycardia
response
et al
function
importance
study
to influence
adrenergic
EGF in cardiac
present
on cardiac
no EGF in
(.I),
the
recognized
Roberts
(-8) found
transport
of
of
hypothesis of intact
the
effect is
cardiac heart
that
of
EGF on cardiac
it
is
electrical is
dependent
operative activity on Na+,
rate
is
through
changes
in cultured CaZ+,
unknown
chick
but in ion hearts
and K+ currents.
an flux. as Each
Vol. 146, No. 2, 1987 of
these
may be operative
calcium
entry
into
increase
heart
a variety
of
mechanism
for
rate
is
which
is
rate cells the
by increasing
of
process. is
e.g.,
the
of
the
of
designed
temperatures
fusion
but
temperature.
smaller
than of cell
automaticity
at
these
the
half
saturated it
is
another
possible beating (13) Na
be due to activation
of
cardiac
is
rate
at
at
the
(17).
crucial
the
A physiologic
by producing
partial
The increase
This
in 896
effect the
effect
of
effect
rate
to
EGF at
is,
thus, study
to a
22oC was much
EGF by hypothermia
depolarization
then after
EGF
37 degrees
response
reduces
rate
of
different
temperature
heart
antagonized
The present
EGF at
heart
of
is
temperatures
effects.
the
EGF (1).
EGF receptor,
compared
of
the
concentration
e.g.,
effects
in
the
greater
lower
in of
of
(4).
at
antagonism
Reduction
step
internalization
degrees
maximum
lysosomes
first
affinity
to affect
in endo-
EGF within
antagonistic
ability
complexes
bodies,
37 degrees
the
the
clustering
multi-vesicular
the
response
the
with
a tenfold
zero
in a stepwise
receptors, of
the
in the
examine
We found
explanation.
of
at
potential
its
to occur
on phosphatases,
increased
these
(18,19).
to
vesicles
shift
chronotropic
cultures
in
EGF may increase
prevent
temperatures
370C.
urn entry
EGF increases
internalization
temperature
than
rather
calci
in culture,
(14).
EGF to surface
the of
to precisely
reduced
in
surface,
in
is
because
rate
of
receptors
on cardiac
interest
part
binding
surface
low
cell
been considered
EGF to
of
will
Na concentrations
thought
degradation
degrees
is
in
calcium
increase
myocytes
Thus,
EGF have
a temperature-dependent
The effect
only
types
and the
on phosphorylation
of
of
is
to
Na+ entry
the
lysosomes,
receptor
extracellular
extracellular
into
Increases
heart.
as well.
and the
effect
was not
Na entry
on the
EGF at zero
by the
of
the
(15,16).
Reductions
There
to
mechanism
its
found
In cardiac
cell
involves
presumably
EGF.
different
effects
vesicles
Binding
of
RESEARCH COMMUNICATIONS
EGF on the
by elevating
Alteration
into
EGF: receptor
of
(11,lZ).
Na entry
The cellular
cytic
produced
proportionate
exchange
that
effects
EGF has been
effect
in several
fashion
cell
AND BIOPHYSICAL
(10).
translated
a Na+/H+
in the
the
directly
uptake
of
BIOCHEMICAL
is
heart depression
isoproterenol
is
C. of
Vol.
146,
No.
also
partially
effect
of
2, 1987
prevented
of
thermia
on the
is
response
on cardiac although
prevented
was different.
This
with
cells
to the
under
binding
BIOPHYSICAL
EGF is
not
hypothesis
studies
suggests
simply
that
less
even the
cells
are
though
effect
to
normothermic required
maximum the
of
hypo-
antagonism.
EGF binding
than
COMMUNICATIONS
EGF, the
a physiologic
rather
in cardiac
to
by hypothermia
of
hypothermic
RESEARCH
In contrast
was not
response
consistent
AND
by hypothermia.
isoproterenol
pattern
It
BIOCHEMICAL
to
its
receptor
conditions come to a definite
conclusion. In summary, in cardiac mediated in cardiac
the
cells by beta cells
present namely
study
an increase
adrenergic is
found
supported
that in
EGF produces
chronotropic
receptors.
functional
response.
An EGF receptor-mediated
by a blunting
of
the
heart
rate
changes This
was not
effect response
to
EGF hy hypothermia. REFERENCES 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 79.
Carpenter, G. and Cohen, S. (1979) Ann. Rev. Biochem. 48, 193-216. In Developmental Sperekalis, N., Shigenbou, K., and McLean, M.J. (1975) Edited by Lieberman, M. and Physiological Correlates of Cardiac Muscle. Raven Press, NY. and Sano, T. Carmeliet, E., and Vereecke, J. (1979) In Handbook of Physiology, Section 2, Sot Bethesda, Maryland USA 269-335. Ed. Berne, R.M. Am Physiol P. (1982) J. Biol. Chem. 257, 3053-3060. King, A.C., and Cuatrecasas, Myrdal, S.E., and De. Haan, R.L. (1983) J. Cell. Physiol. 117, 319-325. Balk, S.D., Riley, T.M., Gunther, H.S., and Morisi, A. (1985) Proc. Natl. Acad. Sci. USA 82, 5781-5. Roberts, A.B., Anzone, M.A., Lamb, L.C., Smith, J.M., and Sporm, M.B. (1981) Proc Nat1 Acad Sci USA 78, 5339-43. Kasselberg, A.G., Orth, D.N., Gray, M.E., and Stahlman, M.T. (1985) J. Histochem Cytochem. 33, 315-322. Fukada, K. (1980) Nature 287, 553-5. Goshima, K, (1975) In Developmental and Physiological Correlates of Cardiac Ed. M. Luberman and T. Sono. Raven Press, NY, 197-208. muscle. and Cohen, S. (1981) Biochemistry 20, 6280-6286. Sawyer, S.T., Moolenaar, W.H., Tertoolen, L.G.J., and de Laat, S.W. (1984) J. Biol. Chem. 259, 8066-8069. McCall, D. (1976) J. Gen Physiol 68, 537-549. Ellis, D. (1977) J. Physiol. 273, 211-240. and Rosengurt, E. (1982) Proc. Nat1 Acad Sci (USA) 79,7783-7787. Smith, J.B., Rothenberg, P., Glasser, L., Schlesinger, P., and Cassel, D. (1983) J. Biol. Chem. 258, 4883-4889. A.M. (1981) Ann NY Acad Carpenter, G., Stoscheck, C.M., and Soderquist, Sci 397, 11-17. I.S. (1972) J. Molec & Cellular Cardiol. 4, 453-463. Boder, G.B., and Johnson, D. (1967) Am. H. Physiol 213, 719-724. Sperekalis, N., and Lehmkuhl, 897